Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
12.5 TWD
1.05 B TWD
4.08 B TWD
43.14 M
About UNIVERSAL VISION BIOTECHNOLOGY CO
Sector
Industry
CEO
Cheng Hung Lu
Website
Headquarters
Taipei
Founded
1994
ISIN
TW0003218004
FIGI
BBG000HZ0592
Universal Vision Biotechnology Co., Ltd. engages in the sale of optical instruments, glasses, contact lenses, and glass ornament. It operates through the following business segments: Optometry, Ophthalmology, and Other. The Ophthalmology Business segment is responsible for providing ophthalmic clinics and hospital technical services and consultancy services and leasing services. The Optometry Business segment consists of the sales of glasses and peripheral equipment. The company was founded on August 3, 1994 and is headquartered in Taipei, Taiwan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 3218 is 200.0 TWD — it has decreased by −1.23% in the past 24 hours. Watch UNIVERSAL VISION BIOTECHNOLOGY CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange UNIVERSAL VISION BIOTECHNOLOGY CO stocks are traded under the ticker 3218.
3218 stock has fallen by −4.53% compared to the previous week, the month change is a −5.21% fall, over the last year UNIVERSAL VISION BIOTECHNOLOGY CO has showed a −26.06% decrease.
We've gathered analysts' opinions on UNIVERSAL VISION BIOTECHNOLOGY CO future price: according to them, 3218 price has a max estimate of 248.00 TWD and a min estimate of 200.00 TWD. Watch 3218 chart and read a more detailed UNIVERSAL VISION BIOTECHNOLOGY CO stock forecast: see what analysts think of UNIVERSAL VISION BIOTECHNOLOGY CO and suggest that you do with its stocks.
3218 reached its all-time high on Apr 19, 2023 with the price of 432.0 TWD, and its all-time low was 16.0 TWD and was reached on Aug 25, 2015. View more price dynamics on 3218 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
3218 stock is 1.50% volatile and has beta coefficient of 0.48. Track UNIVERSAL VISION BIOTECHNOLOGY CO stock price on the chart and check out the list of the most volatile stocks — is UNIVERSAL VISION BIOTECHNOLOGY CO there?
Today UNIVERSAL VISION BIOTECHNOLOGY CO has the market capitalization of 16.95 B, it has decreased by −4.49% over the last week.
Yes, you can track UNIVERSAL VISION BIOTECHNOLOGY CO financials in yearly and quarterly reports right on TradingView.
UNIVERSAL VISION BIOTECHNOLOGY CO is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
3218 earnings for the last quarter are 2.88 TWD per share, whereas the estimation was 3.50 TWD resulting in a −17.62% surprise. The estimated earnings for the next quarter are 3.06 TWD per share. See more details about UNIVERSAL VISION BIOTECHNOLOGY CO earnings.
UNIVERSAL VISION BIOTECHNOLOGY CO revenue for the last quarter amounts to 1.08 B TWD, despite the estimated figure of 1.12 B TWD. In the next quarter, revenue is expected to reach 1.04 B TWD.
3218 net income for the last quarter is 243.65 M TWD, while the quarter before that showed 278.14 M TWD of net income which accounts for −12.40% change. Track more UNIVERSAL VISION BIOTECHNOLOGY CO financial stats to get the full picture.
Yes, 3218 dividends are paid annually. The last dividend per share was 7.00 TWD. As of today, Dividend Yield (TTM)% is 3.50%. Tracking UNIVERSAL VISION BIOTECHNOLOGY CO dividends might help you take more informed decisions.
UNIVERSAL VISION BIOTECHNOLOGY CO dividend yield was 2.53% in 2023, and payout ratio reached 56.75%. The year before the numbers were 2.01% and 59.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIVERSAL VISION BIOTECHNOLOGY CO EBITDA is 1.85 B TWD, and current EBITDA margin is 43.06%. See more stats in UNIVERSAL VISION BIOTECHNOLOGY CO financial statements.
Like other stocks, 3218 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIVERSAL VISION BIOTECHNOLOGY CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UNIVERSAL VISION BIOTECHNOLOGY CO technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UNIVERSAL VISION BIOTECHNOLOGY CO stock shows the sell signal. See more of UNIVERSAL VISION BIOTECHNOLOGY CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.